7Baggers
 Immunovant, Inc. (NASDAQ:IMVT) Q2 2025 Earnings Call Transcript  Insider Monkey Thu, 13 Nov 2025 13:40:44 GMT
 immunovant stock rating reiterated by oppenheimer, cites progress in autoimmune portfolio  Investing.com South Africa Wed, 12 Nov 2025 06:50:07 GMT
 Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus  Yahoo Finance Tue, 11 Nov 2025 17:52:00 GMT
 immunovant, inc. (nasdaq:imvt) q2 2026 earnings call transcript  Insider Monkey Tue, 11 Nov 2025 13:25:31 GMT
 Decoding Immunovant Inc (IMVT): A Strategic SWOT Insight  GuruFocus Tue, 11 Nov 2025 05:22:13 GMT
 Immunovant Reports Q2 2025 Financials and Clinical Progress  TipRanks Tue, 11 Nov 2025 04:09:56 GMT
 Immunovant (IMVT) Receives a Buy from H.C. Wainwright  The Globe and Mail Tue, 11 Nov 2025 01:40:40 GMT
 Immunovant Shares Tumble Amid Insider Selling  TipRanks Mon, 10 Nov 2025 15:04:06 GMT
 Immunovant Bets Big On Autoimmune Drug Pipeline Progress  Finimize Mon, 10 Nov 2025 12:43:40 GMT
 IMMUNOVANT Earnings Results: $IMVT Reports Quarterly Earnings  Quiver Quantitative Mon, 10 Nov 2025 12:30:00 GMT
 autoimmune drugmaker immunovant's q2 net loss misses estimates  MarketScreener Mon, 10 Nov 2025 12:24:53 GMT
 immunovant gains amid takeover speculation  MSN Sat, 08 Nov 2025 18:30:09 GMT
 immunovant (imvt) projected to post quarterly earnings on monday  MarketBeat Tue, 04 Nov 2025 13:06:25 GMT
 immunovant (imvt) soars 14.6% ahead of q3 results  MSN Sun, 02 Nov 2025 13:49:26 GMT
 immunovant gains amid takeover speculation  MSN Sat, 01 Nov 2025 07:07:40 GMT
 immunovant (nasdaq:imvt) sees strong trading volume - time to buy?  MarketBeat Fri, 31 Oct 2025 22:22:31 GMT
 stocks with rising relative strength: immunovant  MSN Fri, 31 Oct 2025 09:08:56 GMT
 published on: 2025-10-31 03:05:59  newser.com Fri, 31 Oct 2025 08:05:59 GMT
 Immunovant (IMVT) Soars 14.6% Ahead of Q3 Results  Yahoo Finance Fri, 31 Oct 2025 07:00:00 GMT
 Immunovant Meets 80-Plus Relative Strength Rating Benchmark  Investor's Business Daily Fri, 31 Oct 2025 07:00:00 GMT
 immunovant gains amid takeover speculation  MSN Thu, 30 Oct 2025 14:23:33 GMT
 Immunovant gains amid takeover speculation (IMVT:NASDAQ)  Seeking Alpha Thu, 30 Oct 2025 07:00:00 GMT
 Immunovant Shares Surge Amid Takeover Rumors  TipRanks Thu, 30 Oct 2025 07:00:00 GMT
 immunovant rumor highlighted in betaville alert  TipRanks Thu, 30 Oct 2025 07:00:00 GMT
 Stocks With Rising Relative Strength: Immunovant  Investor's Business Daily Wed, 29 Oct 2025 07:00:00 GMT
 immunovant (nasdaq:imvt) shares up 7.8% - what's next?  MarketBeat Tue, 28 Oct 2025 20:37:13 GMT

Immunovant, Inc
(NASDAQ:IMVT) 

IMVT stock logo

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phas...

Founded: 2018
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends